Literature DB >> 9789919

Testing strategies in multi-dose experiments including active control.

P Bauer1, J Röhmel, W Maurer, L Hothorn.   

Abstract

Inferential test strategies for multi-arm trials are adapted or proposed for the special situation when more than one dose of a test treatment, placebo and active control(s) are compared. This includes between doses, dose-placebo and dose-active-control comparisons. The procedures refer to situations when detailed comparisons make sense only if the sensitivity of the trial has been shown, for example, if a dose-response relationship or a difference between active control and placebo has been established. Split strategies, hierarchical (assuming an order restriction among doses) or linked procedures are introduced. In linked procedures, equivalence to the active control will be established only if the dose is also shown to be effective as compared to placebo. All the inferential procedures control the experimentwise error rate in the strong sense for the respective sets of null hypotheses considered.

Mesh:

Substances:

Year:  1998        PMID: 9789919     DOI: 10.1002/(sici)1097-0258(19980930)17:18<2133::aid-sim901>3.0.co;2-2

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.

Authors:  Frank Bretz; Martin Posch; Ekkehard Glimm; Florian Klinglmueller; Willi Maurer; Kornelius Rohmeyer
Journal:  Biom J       Date:  2011-08-12       Impact factor: 2.207

2.  Estrogen Down-regulator Fulvestrant Potentiates Antitumor Activity of Fluoropyrimidine in Estrogen-responsive MCF-7 Human Breast Cancer Cells.

Authors:  Mamoru Nukatsuka; Hitoshi Saito; Shinzaburo Noguchi; Teiji Takechi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

3.  Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.

Authors:  Norihiko Suzuki; Hiroshi Tsukihara; Fumio Nakagawa; Takashi Kobunai; Teiji Takechi
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

4.  Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice.

Authors:  Mamoru Nukatsuka; Hitoshi Saito; Fumio Nakagawa; Hiroaki Tsujimoto; Kazuki Sakamoto; Sayaka Tsukioka; Junji Uchida; Mamoru Kiniwa; Takashi Kobunai; Teiji Takechi
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

5.  Adaptive graph-based multiple testing procedures.

Authors:  Florian Klinglmueller; Martin Posch; Franz Koenig
Journal:  Pharm Stat       Date:  2014-10-16       Impact factor: 1.894

6.  Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.

Authors:  Achim J Kaasch; Gerd Fätkenheuer; Reinhild Prinz-Langenohl; Ursula Paulus; Martin Hellmich; Verena Weiß; Norma Jung; Siegbert Rieg; Winfried V Kern; Harald Seifert
Journal:  Trials       Date:  2015-10-09       Impact factor: 2.279

7.  Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts.

Authors:  Hiroshi Tsukihara; Fumio Nakagawa; Kazuki Sakamoto; Keiji Ishida; Nozomu Tanaka; Hiroyuki Okabe; Junji Uchida; Kenichi Matsuo; Teiji Takechi
Journal:  Oncol Rep       Date:  2015-03-23       Impact factor: 3.906

8.  Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study.

Authors:  Frank Albers; Asif Shaikh; Ahmar Iqbal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-11

9.  First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].

Authors:  Ralf H Wittenberg; Ernest Schell; Gerhard Krehan; Roland Maeumbaed; Hans Runge; Peter Schlüter; Taiwo O A Fashola; Helen J Thurston; Klaus J Burger; Ulrich Trechsel
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

10.  The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Kristina Vermeersch; Maria Gabrovska; Griet Deslypere; Ingel K Demedts; Hans Slabbynck; Joseph Aumann; Vincent Ninane; Geert M Verleden; Thierry Troosters; Kris Bogaerts; Guy G Brusselle; Wim Janssens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.